Jennifer Willis

Aston University, department of Health and Life Sciences. Mesenchymal stromal cells, tissue engineering and regenerative medicine.

LifETIME CDT Student.

[LifETIME-CDT @CDTLifETIME]

Can’t believe it’s been two weeks since our joint lifETIME/ BLAST / @ECMage22 conference - Thanks to our brilliant @CdtStudents for their contribution to the event - we look forward to our next conference in June. @UofGlasgow @UofGSciEngGrads #PhD #TeamUofG

[Patrick C Hurley @PatrickC_Hurley]

I had such a wonderful time at the Lake District with @CDTLifETIME so thankful for my friends and future colleagues in the field! Special thanks to @janebalfred and @NML_ChemBioGC Elena Sanchez for our trainings!!

[Formulation Engineering CDT @FormulationCDT]

That’s a wrap for CDT BRUM 2023! The conference was hosted by Formulation Engineering, with 7 different participating CDTs. Students were given the opportunity to network and formally present their research to their peers.

See you all next year!

#CDT #EPSRC

[Jennifer Willis @JennWillis_]

3/ Current #goldstandard methods cannot feasibly meet this demand.

To overcome this, my @CDTLifETIME #PhD project aims to optimise spinner flask systems for the mass production of MSCs for autoimmune-related therapeutics.

Any questions are more than welcome!
#LifETIMETC23

[Jennifer Willis @JennWillis_]

1/ Upscaling #MesenchymalStromalCell (#MSCs) cultures for therapy.

The current annual incidence of #autoimmune conditions is increasing by a rate of 3- 9% worldwide, with ~4 million of the UK population afflicted.

These are highlighted by the loss of immune cell #tolerance.

[Jennifer Willis @JennWillis_]

2/ MSCs are key cells for therapy.

Whilst possessing substantial immuno-suppressive capabilities and capacity for restoring tissue functionality, MSCs do not induce a #graftvhost inflammatory response.

But MSCs are rare and require expansion to become a viable treatment option.

[Amaziah R. Alipio @am4ziah]

Day 2 of the @TheBurnScotland began with a workshop on effective negotiation and entrepreneurship. Followed by an inspiring talk from @CDTLifETIME director @DalbyMatthew

[Jennifer Willis @JennWillis_]

Congrats to everyone involved in this excellent paper in @NatureComms 🎉

A big thank you to @RossLabGroup and @DalbyMatthew for the opportunity to be a part of this exciting research! Here's to many more @JaspreetkBansal!

[Matt Dalby @DalbyMatthew]

Congrats @RossLabGroup - this great paper in
@NatureComms demonstrates (1) that nanotopography can maintain immunomodulatory MSC phenotype and (2) identify activity metabolites to be identified allowing large scale culture.

https://t.co/NkX742Ors8

[Megan Boseley @megan_boseley]

UKEV conference in Edinburgh🤩 and first outing with the @RossLabGroup 🔬 Looking forwards to some interesting talks 👏🏻 @UKEVSoc

[LifETIME-CDT @CDTLifETIME]

Anti-Inflammatory Therapeutics: The Knee-d to Change our Approach

Read our latest blog by @JennWillis_ from @AstonUniversity

https://t.co/j2Dm0yke1Y